217
Views
11
CrossRef citations to date
0
Altmetric
Research Articles

Potent activity of bioconjugated peptide and selenium nanoparticles against colorectal adenocarcinoma cells

, &
Pages 1496-1505 | Received 28 Sep 2018, Accepted 11 Jun 2019, Published online: 05 Jul 2019

References

  • Golubeva OY, Shamova OV, Orlov DS, et al. Synthesis and study of antimicrobial activity of bioconjugates of silver nanoparticles and endogenous antibiotics. Glass Phys Chem. 2011;37:78–84.
  • Nakatsuka N, Barnaby SN, Tsiola A, et al. Self-assembling peptide assemblies bound to ZnS nanoparticles and their interactions with mammalian cells. Colloid Surf B Biointerfaces. 2013;103:405–415.
  • Hermanson GT. Bioconjugation techniques. Vol. 3. Amsterdam, Netherlands: Elsevier; Cambridge (MA): Academic Press; 2013.
  • Algar WR, Dawson P, Medintz IL, editors. Chemoselective and bioorthogonal ligation reactions: concepts and applications. Hoboken (NJ): John Wiley & Sons; 2017.
  • Delehanty JB, Boeneman K, Bradburne CE, et al. Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery. Ther Deliv. 2010;1:411–433.
  • Reches M, Gazit E. Molecular self-assembly of peptide nanostructures: mechanism of association and potential uses. Curr Nanosci. 2006;2:105–111.
  • Groß A, Hashimoto C, Sticht H, et al. Synthetic peptides as protein mimics. Front Bioeng Biotechnol. 2016;3:211.
  • Kafurke U, Erijman A, Aizner Y, et al. Synthetic peptides mimicking the binding site of human acetylcholinesterase for its inhibitor fasciculin 2. J Pept Sci. 2015;21:723–730.
  • Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arabian J. Chem. 2017.
  • Choi DW, Lim MS, Lee JW, et al. The cytotoxicity of kahweol in HT-29 human colorectal cancer cells is mediated by apoptosis and suppression of heat shock protein 70 expression. Biomol Ther. 2015;23:128.
  • Sutradhar KB, Amin ML. Nanotechnology in cancer drug delivery and selective targeting. ISRN Nanotechnol. 2014;2014:1.
  • Bahrami B, Hojjat-Farsangi M, Mohammadi H, et al. Nanoparticles and targeted drug delivery in cancer therapy. Immunol Lett. 2017;190:64–83.
  • Mishra J, Drummond J, Quazi SH, et al. Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis. Crit Rev Oncol Hematol. 2013;86:232–250.
  • Jabir NR, Tabrez S, Ashraf GM, et al. Nanotechnology-based approaches in anticancer research. Int J Nanomed. 2012;7:4391–4408.
  • Ingle AP, Gupta I, Duran N, et al. Nanotherapy: a next generation hallmark for combating cancer. Nanostructures for cancer therapy. Amsterdam, Netherlands: Elsevier; 2017. p. 811–830.
  • Guler E, Demir B, Guler B, et al. BiofuNctionalized nanomaterials for targeting cancer cells. Nanostructures for cancer therapy. 2017. Amsterdam, Netherlands: Elsevier; p. 51–86.
  • Cisterna BA, Kamaly N, Choi WI, et al. Targeted nanoparticles for colorectal cancer. Nanomedicine. 2016;11:2443–2456.
  • Mody VV, Siwale R, Singh A, et al. Introduction to metallic nanoparticles. J Pharm Bioall Sci. 2010;2:282.
  • Kalmodia S, Vandhana S, Rama BT, et al. Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell. Cancer Nano. 2016;7:1.
  • Kogan MJ, Olmedo I, Hosta LR, et al. Peptides and metallic nanoparticles for biomedical applications. Nanomedicine. 2007;2:287–306.
  • Akrami M, Balalaie S, Hosseinkhani S, et al. Tuning the anticancer activity of a novel pro-apoptotic peptide using gold nanoparticle platforms. Sci Rep. 2016;6:31030.
  • Liao W, Zhang R, Dong C, et al. Novel walnut peptide–selenium hybrids with enhanced anticancer synergism: facile synthesis and mechanistic investigation of anticancer activity. Int J Nanomed. 2016;11:1305–1321.
  • Skalickova S, Milosavljevic V, Cihalova K, et al. Selenium nanoparticles as a nutritional supplement. Nutrition. 2017;33:83–90.
  • Wadhwani SA, Shedbalkar UU, Singh R, et al. Biogenic selenium nanoparticles: current status and future prospects. Appl Microbiol Biotechnol. 2016;100:2555–2566.
  • Chaudhary S, Umar A, Mehta SK. Surface functionalized selenium nanoparticles for biomedical applications. J Biomed Nanotechnol. 2014;10:3004–3042.
  • Sperling RA, Parak WJ. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Proc R Soc A. 2010;368:1333–1383.
  • Love JC, Estroff LA, Kriebel JK, et al. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev. 2005;105:1103–1170.
  • Ranjitha VR, Ravishankar VR. Extracellular synthesis of selenium nanoparticles from an actinomycetes streptomyces griseoruber and evaluation of its cytotoxicity on HT-29 cell line. Pharm Nanotechnol. 2018; 6:61–68.
  • Tkachenko A, Xie H, Franzen S, et al. Assembly and characterization of biomolecule-gold nanoparticle conjugates and their use in intracellular imaging. Nanobiotechnology protocols. New York (NY): Humana Press; 2005. p. 85–99.
  • Ramar V, Pappu S. Exploring the inhibitory potential of bioactive compound from Luffa acutangula against NF-κB—a molecular docking and dynamics approach. Comput Biol Chem. 2016;62:29–35.
  • Hajiaghaalipour F, Kanthimathi MS, Sanusi J, et al. White tea (Camellia sinensis) inhibits proliferation of the colon cancer cell line, HT-29, activates caspases and protects DNA of normal cells against oxidative damage. Food Chem. 2015;169:401–410.
  • Saadat YR, Saeidi N, Vahed SZ, et al. An update to DNA ladder assay for apoptosis detection. Bioimpacts. 2015;5:25.
  • Patel VK, Rajak H. Synthesis, biological evaluation and molecular docking studies of 2-amino-3, 4, 5-trimethoxyaroylindole derivatives as novel anticancer agents. Bioorg Med Chem Lett. 2016;26:2115–2118.
  • Jindal P, Paliwaal D, Chaudhary A, et al. In vitro cytotoxicity evaluation and docking studies of benzofurooxepines’ derivatives against human cancer cell lines. Chem Sci Rev Lett. 2015;4:502–508.
  • Ragavan RV, Kumar KM, Vijayakumar V, et al. β-Keto esters from ketones and ethyl chloroformate: a rapid, general, efficient synthesis of pyrazolones and their antimicrobial, in silico and in vitro cytotoxicity studies. Org Med Chem Lett. 2013;3:6.
  • Kojetin DJ, Burris TP, Jensen EV, et al. Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor. Endocr Relat Cancer. 2008;15:851–870.
  • Maus L, Dick O, Bading H, et al. Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors. ACS Nano. 2010;4:6617–6628.
  • Yadav SC, Kumari A, Yadav R. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation. Peptides. 2011;32:173–187.
  • Sapsford KE, Algar WR, Berti L, et al. Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. Chem Rev. 2013;113:1904–2074.
  • Michalek P, Richtera L, Krejcova L, et al. Bioconjugation of peptides using advanced nanomaterials to examine their interactions in 3D printed flow-through device. Electrophoresis. 2016;37:444–454.
  • Zahedifard M, Faraj FL, Paydar M, et al. Synthesis, characterization and apoptotic activity of quinazolinone Schiff base derivatives toward MCF-7 cells via intrinsic and extrinsic apoptosis pathways. Sci Rep. 2015;5:11544.
  • Shafagh M, Rahmani F, Delirezh N. CuO nanoparticles induce cytotoxicity and apoptosis in human K562 cancer cell line via mitochondrial pathway, through reactive oxygen species and P53. Iran J Basic Med Sci. 2015;18:993.
  • Kulandaivelu B, Gothandam KM. Cytotoxic effect on cancerous cell lines by biologically synthesized silver nanoparticles. Braz Arch Biol Technol. 2016;59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.